After Monster Moves Higher, It May Not Be Too Late To Get In On These Top-Performing Pharmaceutical Stocks

2020-07-09 08_16_16-person holding amber glass bottles photo – Free Apparel Image on UnsplashWith their shares having surged by more than 484%, 500% and 275%, respectively, the three stocks highlighted in today’s article are three of the best-performing pharmaceutical stocks over the past year – and despite them having already experienced monster moves higher, it may not be too late to get in on these stocks’ gains. For more on these three pharmaceutical stocks, how much higher each can possibly go, and which may be the safest (and the riskiest) bet, CLICK HERE.

These 2 Small-Cap Biotech And Pharma Stocks Boast “Strong Buy” Ratings And Significant Upside Potential

2020-06-23 20_12_04-Set of pills with heap of paper money · Free Stock PhotoToday’s article highlights two “compelling small-cap stocks that combine a low cost of entry with the Street’s backing.” More specifically, these two stocks – a biotech firm and a pharmaceutical company – are currently trading for less than $8 a share, have earned “Strong Buy” consensus analyst ratings, and boast significant upside potential. For more, CLICK HERE.

Are Any Of These 10 Potential Retirement Ruiners In Your Portfolio?

2017-01-15 17_49_26-Black Frame Eyeglasses Near White Ceramic Mug · Free Stock PhotoThe ten stocks identified in today’s article may be nice stocks to trade for short-term profit, but you may not want to bet your retirement portfolio on them. Specifically, the author identifies ten stocks that he argues “are more likely to hurt your retirement than help it” as they lack what he sees as the critical feature for retirement stocks: being future proof. To find out what these ten potential retirement ruiners are – and why they may not be as future proof as they may seem – CLICK HERE.